Abbott Laboratories (ABT)
Abbott Laboratories (ABT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 2,488 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,877 | 3,038 | 1,025 | 1,960 | 2,705 | 2,868 | 1,417 | 2,047 | 2,787 | 3,315 | 1,315 | 2,488 | 9,905 | |
| 824 | 813 | 805 | 805 | 801 | 807 | 756 | 777 | 791 | 792 | 730 | 1,013 | 3,326 | |
| 117 | 114 | 304 | 141 | 117 | 111 | 289 | 142 | 120 | 113 | 317 | 168 | 718 | |
| 117 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -2,866 | -1,524 | -561 | -428 | 163 | -8,391 | -953 | -651 | 232 | 569 | -882 | 734 | 653 | |
| 560 | 755 | 398 | 533 | 556 | 720 | 484 | 502 | 496 | 689 | 399 | 399 | 1,983 | |
| -634 | -824 | -425 | -453 | -594 | -866 | -470 | -582 | -457 | -913 | -20,324 | -673 | -22,367 | |
| 888 | 888 | 957 | 961 | 960 | 958 | 1,026 | 1,029 | 1,031 | 1,030 | 1,098 | 1,102 | 4,261 | |
| -835 | -259 | -226 | -3.0 | -751 | -315 | -280 | -6.0 | -305 | -302 | -180 | -1,045 | -1,832 | |
| -1,506 | – | – | – | 43 | -613 | -1,036 | -15 | -493 | -70 | 18,475 | – | – | |
| -2,340 | -2,052 | -1,176 | -791 | -1,576 | -1,861 | -2,055 | -1,097 | -1,760 | -1,397 | 17,313 | -3,518 | 10,638 | |
| -1,126 | 187 | -612 | 703 | 571 | 58 | -1,084 | 419 | 560 | 1,011 | -1,719 | -1,699 | -1,847 | |
| 1,317 | 2,283 | 627 | 1,427 | 2,149 | 2,148 | 933 | 1,545 | 2,291 | 2,626 | 916 | 2,887 | 8,720 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.